118 related articles for article (PubMed ID: 22685558)
21. Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163
Kwak M; Erdag G; Leick KM; Bekiranov S; Engelhard VH; Slingluff CL
J Transl Med; 2021 Aug; 19(1):371. PubMed ID: 34454518
[TBL] [Abstract][Full Text] [Related]
22. Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
Liu J; Zhou Z; Ma L; Li C; Lin Y; Yu T; Wei JF; Zhu L; Yao G
Cancer Cell Int; 2021 Aug; 21(1):453. PubMed ID: 34446007
[TBL] [Abstract][Full Text] [Related]
23. Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma.
Meyer S; Handke D; Mueller A; Biehl K; Kreuz M; Bukur J; Koehl U; Lazaridou MF; Berneburg M; Steven A; Massa C; Seliger B
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359808
[TBL] [Abstract][Full Text] [Related]
24. Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma.
Werner F; Wagner C; Simon M; Glatz K; Mertz KD; Läubli H; Richtig E; Griss J; Wagner SN
Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359321
[TBL] [Abstract][Full Text] [Related]
25. Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical Signature.
Reschke R; Gussek P; Ziemer M
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200680
[TBL] [Abstract][Full Text] [Related]
26. Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics.
Chen M; Werner F; Wagner C; Simon M; Richtig E; Mertz KD; Griss J; Wagner SN
Front Cell Dev Biol; 2021; 9():677944. PubMed ID: 34095149
[No Abstract] [Full Text] [Related]
27. Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Pidò S; Ceddia G; Masseroli M
NPJ Syst Biol Appl; 2021 Mar; 7(1):17. PubMed ID: 33712625
[TBL] [Abstract][Full Text] [Related]
28. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives.
Bobrowicz M; Zagozdzon R; Domagala J; Vasconcelos-Berg R; Guenova E; Winiarska M
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31554169
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of B cells in cutaneous melanoma.
Selitsky SR; Mose LE; Smith CC; Chai S; Hoadley KA; Dittmer DP; Moschos SJ; Parker JS; Vincent BG
Genome Med; 2019 May; 11(1):36. PubMed ID: 31138334
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma.
Irvine M; Stewart A; Pedersen B; Boyd S; Kefford R; Rizos H
Oncogenesis; 2018 Sep; 7(9):72. PubMed ID: 30237495
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathology of cutaneous melanoma.
van Kempen LC; Redpath M; Robert C; Spatz A
Melanoma Manag; 2014 Nov; 1(2):151-164. PubMed ID: 30190820
[TBL] [Abstract][Full Text] [Related]
33. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C
Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176
[TBL] [Abstract][Full Text] [Related]
34. Specific Targeting of
Tang B; Lee HO; An SS; Cai KQ; Kruger WD
Cancer Res; 2018 Aug; 78(15):4386-4395. PubMed ID: 29844120
[TBL] [Abstract][Full Text] [Related]
35. Emerging Biomarkers in Cutaneous Melanoma.
Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.
Somasundaram R; Zhang G; Fukunaga-Kalabis M; Perego M; Krepler C; Xu X; Wagner C; Hristova D; Zhang J; Tian T; Wei Z; Liu Q; Garg K; Griss J; Hards R; Maurer M; Hafner C; Mayerhöfer M; Karanikas G; Jalili A; Bauer-Pohl V; Weihsengruber F; Rappersberger K; Koller J; Lang R; Hudgens C; Chen G; Tetzlaff M; Wu L; Frederick DT; Scolyer RA; Long GV; Damle M; Ellingsworth C; Grinman L; Choi H; Gavin BJ; Dunagin M; Raj A; Scholler N; Gross L; Beqiri M; Bennett K; Watson I; Schaider H; Davies MA; Wargo J; Czerniecki BJ; Schuchter L; Herlyn D; Flaherty K; Herlyn M; Wagner SN
Nat Commun; 2017 Sep; 8(1):607. PubMed ID: 28928360
[TBL] [Abstract][Full Text] [Related]
37. Genetic Variants in WNT2B and BTRC Predict Melanoma Survival.
Shi Q; Liu H; Han P; Li C; Wang Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
J Invest Dermatol; 2017 Aug; 137(8):1749-1756. PubMed ID: 28499756
[TBL] [Abstract][Full Text] [Related]
38. The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.
Flynn NJ; Somasundaram R; Arnold KM; Sims-Mourtada J
Target Oncol; 2017 Apr; 12(2):139-152. PubMed ID: 28281220
[TBL] [Abstract][Full Text] [Related]
39. Immunology Comes Full Circle in Melanoma While Specific Immunity Is Unleashed to Eliminate Metastatic Disease, Inflammatory Products of Innate Immunity Promote Resistance.
Grimm EA
Crit Rev Oncog; 2016; 21(1-2):57-63. PubMed ID: 27481002
[TBL] [Abstract][Full Text] [Related]
40. TMAinspiration: Decode Interdependencies in Multifactorial Tissue Microarray Data.
Boecker F; Buerger H; Mallela NV; Korsching E
Cancer Inform; 2016; 15():143-9. PubMed ID: 27398021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
